The ISPE RWE Task Force promotes global knowledge exchange of scientific methods and standards, education, and policies related to the development, implementation, and interpretation of Real-World Evidence generated from Real-World Data to study the utilization, effectiveness, and safety of treatment interventions in population health. The task force will:
1. Coordinate and consolidate the 30+ years of rich expertise in the science of pharmacoepidemiology research by effectively connecting ISPE members across academia, government, service providers and pharmaceutical industries from over 50 countries; and
2. Foster collaborations with other societies, agencies, academic institutions, and patient advocacy groups
Connect with ISPE RWE
RWE TF Community - Connect with RWE Task Force co-chairs
RWE TF Newsletter: April 2020 issue; July 2020 issue; December 2020 issue; March 2021 issue;
July 2021 issue; January 2022 issue
Real-World Evidence Task Force
Co-Chairs
Helga Gardarsdottir
Donna Rivera
RWE Reproducibility and Transparency and Collaboration with ISPOR
Co-Chairs
Anton Pottegård
Shirley Wang
Elena Petelos
RWE and Regulatory Decision Making
Co-Chairs
Karolina Andersson Sundell
Cynthia Girman, FISPE
Member List
RWE and Real-World Data Sources
Co-Chairs
Kenneth Man
Annie McNeill
Member List
RWE and Oncology
Co-Chairs
Deborah Layton
Donna Rivera
Member List
RWE Statistical Methods
Co-Chairs
Rolf Groenwold
Jeremy Rassen
Member List
RWE and Collaboration with DIA
Co-Chairs
Kinwei Chan, FISPE
Patrice Verpillat
Member List
RWE and Collaboration with Duke Margolis
Co-Chairs
Christina DeFilippo-Mack
David Miller, FISPE
Member List
Manuscript Development
Co-Chairs
Mehmet Burcu
Darren Toh, FISPE
Member List
RWE Website Contents
Co-Chairs
Meredith Smith
Rachel Sobel, FISPE
Member List
RWE Methods Training
Co-Chairs
Joshua Gagne
Christopher Rentsch
Member List
RWE and Medical Device
Co-Chairs
Daniel Prieto-Alhambra, FISPE
Mary Ritchey, FISPE
Member List
RWE and COVID-19
Co-Chairs
Montse Soriano Gabarro
Ann McMahon
